Prostate cancer and supplementation with α-tocopherol and β-carotene: Incidence and mortality in a controlled trial

Journal of the National Cancer Institute

Volumn 90, Issue 6, 1998, Pages 440-446

  Heinonen, Olli P ^a   Albanes, Demetrius ^b   Virtamo, Jarmo ^c   Taylor, Philip R ^b   Huttunen, Jussi K ^c   Hartman, Anne M ^b   Haapakoski, Jaason ^c   Malila, Nea ^c   Rautalahti, Matti ^c   Ripatti, Samuli ^c   Mäenpää, Hanna ^d   Teerenhovi, Lasse ^d   Koss, Leopold ^e   Virolainen, Martti ^d   Edwards, Brenda K ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SMOKING;

EID: 0032542759     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.6.440     Document Type: Article

References (43)

1. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol 1991;30:133-40.
2. Nomura AM, Kolonel LN. Prostatic cancer: a current perspective. Epidemiol Rev 1991;13:200-27.
3. Gittes RF. Carcinoma of the prostate. N Engl J Med 1991;324:236-45.
4. Boyle P, Zaridze DG. Risk factors for prostate and testicular cancer. Eur J Cancer 1993;29A:1048-55.
5. Bosland MC. The etiopathogenesis of prostatic cancer with special reference to environmental factors. Adv Cancer Res 1988;51:1-106.
6. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1993;118:793-803.
7. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 1994;4:1-10.
8. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
9. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et al. α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alph-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
10. Pietinen P, Hartman AM, Haapa E, Rasanen L, Haapakoski J, Palmgren J, et al. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988;128:655-66.
11. Milne DB, Botnen J, Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32:874-6.
12. Pettersson K, Piironen T, Seppala M, Liukkonen L, Christensson A, Matikainen MT, et al. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. Clin Chem 1995;41:1480-8.
13. Kyllonen LE, Teppo L, Lehtonen M. Completeness and accuracy of registration of colorectal cancer in Finland. Ann Chir Gynaecol 1987;76: 185-90.
14. Pukkala E. Use of record linkage in small-area studies. In: Elliott P, Cuzick J, English D, Stern R, editors. Geographical and Environmental Epidemiology: Methods for Small-Area Studies. Oxford: Oxford Univ Press; 1992:125-31.
15. Beahrs OH, Henson DE, Mutter RV, Kennedy BJ, editors. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia: Lippincott, 1992.
16. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall, 1984.
17. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.
18. Willett WC, Polk BF, Underwood BA, Stampfer MJ, Pressel S, Rosner B, et al. Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 1984;310:430-4.
19. Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, et al. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 1988;127:28-41.
20. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-6.
21. Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County (MD). Am J Clin Nutr 1991;53:260S-264S.
22. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
23. Eichholzer M, Stahelin HB, Gey KF, Ludin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 1996;66:145-50.
24. Prasad KN, Edwards-Prasad J. Vitamin E and cancer prevention: recent advances and future potentials. J Am Coll Nutr 1992;11:487-500.
25. Meydani M. Vitamin E. Lancet 1995;345:170-5.
26. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group [published erratum appears in JAMA 1997;277:1520]. JAMA 1996;276:1957-63.
27. Ecken RE, Schreier U, Drescher P, Madsen PO, Derouet H, Becht E, et al. Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia. Urol Int 1995;54:6-21.
28. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
29. Graham S, Haughey B, Marshall J, Priore R, Byers T, Rzepka T, et al. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 1983;70:687-92.
30. Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol 1988;127:999-1012.
31. Heshmat MY, Kaul L, Kovi J, Jackson MA, Jackson AG, Jones GW, et al. Nutrition and prostate cancer: a case-control study. Prostate 1985;6:7-17.
32. West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 1991;2:85-94.
33. Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E. Diet and prostatic cancer: a case-control study in northern Italy. Nutr Cancer 1992;18:277-86.
34. Schuman LM, Mandel JS, Radke A, Seal U, Halberg F. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota case-control study, 1976-1979. In: Magnus K, editor. Trends in cancer incidence: causes and practical implications. Washington (DC): Hemisphere. 1982;345-54.
35. Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 1987;78:869-74.
36. Ohno Y, Yoshida O, Oishi K, Okada K, Yamabe H, Schroeder FH. Dietary β-carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res 1988;48:1331-6.
37. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer 1989;64:605-12.
38. Rohan TE, Howe GR, Burch JD, Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control 1995;6:145-54.
39. Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr 1979;53:149-55.
40. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Vitamin A, β-carotene, and the risk of cancer: a prospective study. J Natl Cancer Inst 1987;79:443-8.
41. Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 1990;50:6836-40.
42. Daviglus ML, Dyer AR, Persky V, Chavez N, Drum M, Goldberg J, et al. Dietary beta-carotene, vitamin C, and risk of prostate cancer: results from the Western Electric Study. Epidemiology 1996;7:472-7.
43. Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, et al. Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol 1990;132:857-70.